2008-2017年瑞典症状性颈动脉狭窄治疗后迟发性同侧缺血性卒中发生率低:老年及颈动脉支架置入术后风险增加
基于瑞典血管外科全国登记(Swedvasc)与卒中登记(Riksstroke)的队列研究,纳入2008-2017年因症状性颈动脉狭窄接受治疗的7589例患者,随访4.2±2.6年。围手术期后同侧缺血性卒中年发生率为0.73%,年龄>80岁较65-79岁(校正HR 1.94,95%CI 1.43-2.65)及颈动脉支架置入术(CAS)较颈动脉内膜切除术(CEA)(校正HR 3.20,95%CI 2.03-5.03)与同侧缺血性卒中风险增加相关。
要点
- 症状性颈动脉狭窄治疗后同侧缺血性卒中年发生率为0.73%。
- 年龄>80岁较65-79岁同侧缺血性卒中风险增加(校正HR 1.94,95%CI 1.43-2.65)。
- CAS较CEA同侧缺血性卒中风险增加(校正HR 3.20,95%CI 2.03-5.03)。
核心结论
- 2008-2017年瑞典症状性颈动脉狭窄治疗后同侧缺血性卒中发生率低,显示手术在真实世界中的有效性和持久性。
- 仅年龄>80岁和CAS较CEA与同侧缺血性卒中风险增加相关。
研究设计与样本
- 全国性、基于登记处的队列研究,使用瑞典国家血管外科登记(Swedvasc)建立队列,瑞典卒中登记(Riksstroke)结合医院记录确定结局。
- 纳入2008-2017年瑞典因症状性颈动脉狭窄接受治疗的患者共7589例(平均年龄72±8岁,男性68%),随访4.2±2.6年。
- 研究围手术期(≤30天)后同侧缺血性卒中,次要结局为围手术期后任何类型卒中和全因死亡,采用Cox回归分析临床因素与结局的关联。
主要发现
- 同侧缺血性卒中发生于232例患者,年发生率为0.73%。
- 年龄>80岁较65-79岁与同侧缺血性卒中风险增加相关(校正HR 1.94,95%CI 1.43-2.65)。
- CAS较CEA与同侧缺血性卒中风险增加相关(校正HR 3.20,95%CI 2.03-5.03)。
- 任何类型卒中发生于7.7%的患者,19.6%的患者在随访期间死亡。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Carotid stenosis is a major risk factor for stroke and surgical treatment is key in preventing recurrent ischaemic events. Previous randomised trials have demonstrated the net benefit of surgery for significant symptomatic carotid stenosis but, with present day medical treatment, there is limited evidence on the risk of late ipsilateral ischaemic stroke (IS) and its main risk factors. METHOD: Ipsilateral IS after the peri-operative period (≤ 30 days) was investigated in a nationwide, registry based cohort study of patients treated for symptomatic carotid stenosis in Sweden between 2008 - 2017. The Swedish National Registry for Vascular Surgery (Swedvasc) was used to establish the cohort, and the Swedish stroke registry (Riksstroke), combined with hospital records, was used to determine outcome. Stroke of any type and all cause mortality after the peri-operative period were studied as secondary outcomes. Cox regression was used to analyse associations between clinical factors and outcomes. RESULTS: In total, 7 589 patients (mean age 72 ± 8 years, 68% men) were followed for 4.2 ± 2.6 years. Ipsilateral IS occurred in 232 patients corresponding to a yearly incidence of 0.73%. Age above 80 years compared with 65 - 79 years was associated with an increased risk of ipsilateral IS (adjusted HR 1.94, 95% CI 1.43 - 2.65). Carotid artery stenting (CAS) compared with carotid endarterectomy (CEA) was also associated with increased risk (adjusted HR 3.20, 95% CI 2.03 - 5.03). Stroke of any type occurred in 7.7% of patients, and 19.6% of patients died during the follow up period. CONCLUSION: The incidence of ipsilateral IS after treatment for symptomatic carotid stenosis in Sweden 2008-2017 was low, demonstrating the effectiveness and durability of surgery in a real world setting. Only age above 80 years and CAS compared with CEA were associated with increased risk of ipsilateral IS.
引用
- Hammar K, Laska AC, Wester P, et al. Low Incidence of Late Ipsilateral Ischaemic Stroke After Treatment for Symptomatic Carotid Stenosis in Sweden 2008-2017: Increased Risk in the Elderly and After Carotid Stenting. Eur J Vasc Endovasc Surg. 2021. PMID: 34794877. doi:10.1016/j.ejvs.2021.09.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。